Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)
NCT00015587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3523
Last updated 2016-10-12
Summary
This study is a case-control study investigating the causes of childhood leukemia in Northern California. The overall purpose of this epidemiologic study is to find specific genetic or environmental factors that may increase the risk of leukemia in children. The study is being conducted by Patricia Buffler, PhD at the School of Public Health - University of California Berkeley in collaboration with the California Department of Health Services and 16 hospitals located throughout the state of California. The study began in 1995 and will continue to 2014.
Conditions
- Leukemia
- Acute Myelocytic Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Catherine Metayer, MD, PhD · University of California Berkeley, School of Public Health
Eligibility
- Min Age
- 1 Day
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-04-30
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002704 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00002816 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Study of Gene Alterations in Children Who Have Been Treated for Relapsed Acute Lymphocytic Leukemia
NCT00003933 ·Status: COMPLETED ·Phase: NA
-
Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia
NCT00313053 ·Status: TERMINATED ·Phase: PHASE1
-
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
NCT00083070 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia
NCT00001689 ·Status: COMPLETED ·Phase: PHASE1
-
Genetic Polymorphisms in Drug Induced Neuropathy in Children With ALL
NCT05811910 ·Status: UNKNOWN
-
Treatment of Childhood Acute Lymphoblastic Leukemia
NCT00165087 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 ·Status: COMPLETED ·Phase: PHASE3
-
Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma
NCT00020111 ·Status: COMPLETED ·Phase: PHASE1
-
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
NCT00042796 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005585 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
NCT02932280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
NCT00085176 ·Status: COMPLETED
-
Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
NCT00006462 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors
NCT00003073 ·Status: UNKNOWN ·Phase: PHASE1
-
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
NCT00019409 ·Status: WITHDRAWN ·Phase: PHASE3
-
LIFE Cancer Survivorship Database for Pediatric Cancer
NCT01518400 ·Status: RECRUITING
-
Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia
NCT00015873 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 and Childhood Cancer
NCT06482281 ·Status: ACTIVE_NOT_RECRUITING
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3
NCT05969600 ·Status: COMPLETED
-
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00003735 ·Status: COMPLETED ·Phase: PHASE2
-
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
NCT00458744 ·Status: WITHDRAWN ·Phase: PHASE1
-
Nutrition in Pediatric Oncology in Central America
NCT03976830 ·Status: COMPLETED